Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Capital Reinvestment Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Capital Reinvestment Ratio of 0.63x as of December 2025, meaning it reinvests 1% of its operating cash flow (₫213.49 Billion) in capital expenditures (₫135.54 Billion). Check Binh Dinh Pharmaceutical and Medical Equ tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Binh Dinh Pharmaceutical and Medical Equipment JSC Capital Reinvestment Ratio (2020–2025)
This chart tracks Binh Dinh Pharmaceutical and Medical Equipment JSC's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Binh Dinh Pharmaceutical and Medical Equ (DBD) cash flow conversion.
Annual Capital Reinvestment Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year Capital Reinvestment Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. See cash generation quality of Binh Dinh Pharmaceutical and Medical Equ to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | ₫615.19 Billion | ₫408.57 Billion | ▲ +18.2% |
| 2024 | 0.56x | ₫264.73 Billion | ₫148.75 Billion | ▲ +23.6% |
| 2023 | 0.45x | ₫293.99 Billion | ₫133.69 Billion | ▼ -9.4% |
| 2022 | 0.50x | ₫165.01 Billion | ₫82.83 Billion | ▲ +8.0% |
| 2021 | 0.46x | ₫117.57 Billion | ₫54.64 Billion | ▲ +65.6% |
| 2020 | 0.28x | ₫212.91 Billion | ₫59.73 Billion | — |